Posts

‘Charge density wave’ linked to atomic distortions in w...

UPTON, NY—What makes some materials carry current with no resistance? Scientists...

Uncovering universal physics in the dynamics of a quant...

New experiments using one-dimensional gases of ultra-cold atoms reveal a univers...

African Killifish could hold secrets to reversing muscl...

As we age, our muscles start to waste. Called sarcopenia, it happens to us all, ...

FDA approves drug for night sweats and hot flashes trea...

The FDA announced on Friday that a new non-hormonal medication, Veozah, also kno...

IntraOp Announces Phase II Trial for Carcinoma Therapy

IntraOp Medical Corporation has announced the second phase of the first-ever Ele...

Nido’s precision approach to brain drugs secures $109M ...

Amid the difficulties of the biotech market at present, investors are inclined t...

Phase I completion of Sanofi’s vWD therapy demonstrates...

Sanofi’s announcement provides a more positive outlook for the vWD market as it ...

Juno Pharmaceuticals buys Omega Laboratories

The merged entity represents one of the biggest specialist generic injectable op...

Nuvectis Pharma receives IND approval from FDA for NXP900

NXP900 is a new inhibitor of the SRC family of kinases with low nanomolar effect...

Gilead and Arcus Biosciences expand research collaborat...

Arcus will commence research programmes against up to four targets for inflammat...

Research consortium picks eight rare diseases to advanc...

The Accelerating Medicines Partnership Bespoke Gene Therapy Consortium plans to ...

Market cap downturn hits over half of top 20 biopharmac...

More than half of the top 20 global biopharmaceutical companies saw a fall in ma...

UniQure sells part of Hemgenix royalty rights in deal w...

UniqQure sold a part of its royalty rights for haemophilia B gene therapy to dev...

Bavarian Nordic completes travel vaccine deal with Emer...

The acquisition of Emergent’s portfolio includes vaccines for typhoid fever, cho...

Byondis receives CRL from US FDA for SYD985 BLA

The regulator requested more information that will need additional time and reso...

CHARM Therapeutics secures funding for oncology drug di...

The investment will allow the company to continue to fund its growing organisati...